SYK STRYKER CORPORATION

Stryker named to the 100 Best Companies to Work For list for 10th consecutive year

Stryker named to the 100 Best Companies to Work For list for 10th consecutive year

Kalamazoo, Michigan, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – February 18, 2020 – Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today it has been named one of in its annual survey and evaluation of top-rated workplaces in the United States for a 10th consecutive year. The list recognizes companies that have exceptional workplace cultures and Stryker was ranked #8.  

“Being named to the 100 Best Companies to Work For list for a decade is an honor that we attribute to our people and culture,” said Katy Fink, Vice President, Chief Human Resources Officer, Stryker. “Our employees are driven to deliver on our mission to make healthcare better. We celebrate them and their many contributions that make Stryker a great place to work.”

Fortune partners with research firm Great Place to Work (GPTW) to create the list. GPTW scores each company on its analysis of anonymous employee responses to more than 60 questions on the Trust Index Survey. More than 650,000 employees from various companies in the United States participated in the survey. In addition, GPTW evaluated each companies’ programs and practices as measured through its Culture Audit© assessment.

GPTW ranks the 100 Best Companies to Work For by comparing participants’ scores against similarly sized peers to choose companies that perform the best on characteristics such as being a great place to work for all, executive team effectiveness, innovation and people-focused programs. GPTW research shows that list winners outperform the stock market, beating industry rivals when it comes to talent retention and demonstrating higher levels of productivity than their peers.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at .

Contacts

For investor inquiries please contact:

Katherine Owen, Vice President, Strategy & Investor Relations at 269-385-2600 or

For media inquiries please contact:

Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or

EN
18/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRYKER CORPORATION

 PRESS RELEASE

Stryker declares an $0.88 per share quarterly dividend

Stryker declares an $0.88 per share quarterly dividend Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at the close of business on December 31, 2025, representing an increase of 4.8% versus the prior year and previous quarter.  “We remain confident in our ability to deliver strong financial performance, and consistent with our capital allocation priorities we are increasing our dividend to $0.88 per share,” said Kevin Lobo...

 PRESS RELEASE

Stryker names Spencer Stiles President and Chief Operating Officer

Stryker names Spencer Stiles President and Chief Operating Officer Dylan Crotty promoted to Group President, Orthopaedics Portage, Michighan, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today Spencer Stiles has been appointed President and Chief Operating Officer (COO), effective January 1, 2026. In this role, Stiles will lead the company’s global businesses, strategy, and mergers and acquisitions. “Appointing Spencer President and COO strengthens our ability to sustain high growth and leverage the breadth of our portfolio,” ...

Stryker Corporation - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Stryker Corp: 1 director

A director at Stryker Corp sold 520,000 shares at 355.012USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

 PRESS RELEASE

Stryker reports third quarter 2025 operating results

Stryker reports third quarter 2025 operating results Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter Results Reported net sales increased 10.3% to $6.1 billionOrganic net sales increased 9.5%Reported operating income margin of 18.7%Adjusted operating income margin(1) increased 90 bps to 25.6%Reported EPS increased 2.8% to $2.22Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch